Osteoarthritis (OA) is a condition that is very common amongst the elderly and one that, for many, negatively affects their quality of life by causing a great deal of debility, and causing a dependency on pain medications (NSAIDS). OA is basically a degenerative condition of the joints whereby inflammatory markers seem to be the most important mediators of this cartilage destruction. Keep in mind that cartilage is able to repair itself through the induction of local growth factors, leading to the production of new collagen. This ‘regenerative’ repair is counteracted by the continual destruction seen with this disorder, leading to a progressive degenerative state. Since HBOT is considered to be a regenerative therapy, it would make sense that HBOT could help with a degenerative condition like OA. HBOT is already being used by OA sufferers for its anti-inflammatory pain-relieving effects, but now this study gives us insights on its potential long term benefits on reducing the net destruction and degeneration observed in OA. Researches were able to show that HBOT can benefit OA by helping with both factors that are involved in this disease. Firstly, HBOT caused a marked reduction of the key inflammatory markers involved this condition; thereby, reducing further degeneration. Secondly, HBOT caused an increase in the number of growth factors involved in the production of new collagen and cartilage formation, thus helping in the repair and regeneration of this tissue. The clinical relevance of this study is enormous, as it may offer OA sufferers the ability to counteract the degradative forces involved in OA, while still offering its pain-relieving benefits <view study>